Grau E - Search Results

1

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.

Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Grau E, et al. J Cancer Res Clin Oncol. 2010 Sep;136(9):1415-21. doi: 10.1007/s00432-010-0796-9. Epub 2010 Feb 7. J Cancer Res Clin Oncol. 2010. PMID: 20140741

2

The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma.

Oltra S, Martinez F, Orellana C, Grau E, Fernandez JM, Cañete A, Castel V. Oltra S, et al. Among authors: grau e. Diagn Mol Pathol. 2005 Mar;14(1):53-7. doi: 10.1097/01.pas.0000149876.32376.c0. Diagn Mol Pathol. 2005. PMID: 15714065 Clinical Trial.

3

There is no evidence that the SDHB gene is involved in neuroblastoma development.

Grau E, Oltra S, Orellana C, Hernández-Martí M, Castel V, Martínez F. Grau E, et al. Oncol Res. 2005;15(7-8):393-8. doi: 10.3727/096504005776449671. Oncol Res. 2005. PMID: 16491957

4

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.

Grau E, Oltra S, Martínez F, Orellana C, Cañete A, Fernández JM, Hernández-Martí M, Castel V. Grau E, et al. J Cancer Res Clin Oncol. 2009 Apr;135(4):523-31. doi: 10.1007/s00432-008-0484-1. Epub 2008 Sep 27. J Cancer Res Clin Oncol. 2009. PMID: 18820946

5

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease.

Grau E, Martinez F, Orellana C, Canete A, Yañez Y, Oltra S, Noguera R, Hernandez M, Bermúdez JD, Castel V. Grau E, et al. Mol Carcinog. 2011 Mar;50(3):153-62. doi: 10.1002/mc.20700. Epub 2010 Nov 23. Mol Carcinog. 2011. PMID: 21104989

6

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Yáñez Y, Grau E, Oltra S, Cañete A, Martínez F, Orellana C, Noguera R, Palanca S, Castel V. Yáñez Y, et al. Among authors: grau e. J Cancer Res Clin Oncol. 2011 Aug;137(8):1263-72. doi: 10.1007/s00432-011-0997-x. Epub 2011 Jun 25. J Cancer Res Clin Oncol. 2011. PMID: 21706131

7

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.

Yáñez Y, Hervás D, Grau E, Oltra S, Pérez G, Palanca S, Bermúdez M, Márquez C, Cañete A, Castel V. Yáñez Y, et al. Among authors: grau e. J Cancer Res Clin Oncol. 2016 Mar;142(3):573-80. doi: 10.1007/s00432-015-2054-7. Epub 2015 Oct 24. J Cancer Res Clin Oncol. 2016. PMID: 26498952

8

Minimal residual disease in neuroblastoma: to GAGE or not to GAGE.

Oltra S, Martínez F, Orellana C, Grau E, Fernández JM, Cañete A, Castel V. Oltra S, et al. Among authors: grau e. Oncol Res. 2004;14(6):291-5. doi: 10.3727/096504003773994824. Oncol Res. 2004. PMID: 15206491

9

Molecular biology of neuroblastoma.

Castel V, Grau E, Noguera R, Martínez F. Castel V, et al. Among authors: grau e. Clin Transl Oncol. 2007 Aug;9(8):478-83. doi: 10.1007/s12094-007-0091-7. Clin Transl Oncol. 2007. PMID: 17720650 Review.

10

Advances in neuroblastoma research.

Castel V, Grau E. Castel V, et al. Among authors: grau e. Clin Transl Oncol. 2006 Oct;8(10):701-2. doi: 10.1007/s12094-006-0114-9. Clin Transl Oncol. 2006. PMID: 17074666 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters